NOVERA COMPOUNDS

GHRP-6 5mg

10% off, code: PEPTEN
Purity Guarantee

GHRP-6 5mg

Sign in to view pricing and purchase this product.

Log In Sign Up
Quantity Discount (%) Price
1 - 5 — $35.00
6 - 10 8.57 % $32.00
11 - 20 17.14 % $29.00
21+ 22.86 % $27.00

Why choose Novera Compounds peptides

Research-grade Quality

Every compound is manufactured to research-grade standards and intended strictly for laboratory and research use. Consistent quality you can build a reproducible protocol around.

Documented and traceable

  • Batch number on every vial

  • Published Certificates of Analysis

  • Purity verified by third-party testing

Handled and shipped with care

Temperature-sensitive compounds are stored and shipped under controlled conditions, so material arrives in the state your research requires. Expert support on hand at every step.

About the product

GHRP-6 (5mg), or growth hormone-releasing peptide 6, is a synthetic hexapeptide developed for laboratory investigation into endocrine signaling and metabolic activity. It consists of six amino acids and has a molecular weight of approximately 873.03 g/mol. It is produced using controlled peptide synthesis to achieve research-grade purity suitable for experimental applications.

In laboratory environments, GHRP-6 is typically supplied as a lyophilized powder in a sterile 5 mg vial, enabling precise reconstitution and handling in accordance with defined protocols. This format supports consistent preparation across different study conditions. Current research has explored how this peptide interacts with biological systems involved in cellular communication, hormone-related signaling, and metabolic processes.

Additional studies have examined how varying concentrations and exposure conditions influence peptide behavior in controlled models. These investigations aim to better understand signaling patterns and regulatory responses associated with peptide-driven activity, while remaining within strictly experimental contexts.

GHRP-6 (5mg) Key Features & Specs

GHRP-6 (5mg) is prepared for use in controlled laboratory environments where consistency and accurate peptide characterization are essential. The GHRP-6 peptide is commonly included in studies examining endocrine signaling and cellular response mechanisms. As part of ongoing research, it supports experimental protocols involving hormone-related pathways and metabolic activity.

  • Subcategory: Muscle Growth & Performance Peptides
  • Strength: 5 mg
  • CAS: 87616-84-0
  • Chemical Formula: C₄₆H₅₆N₁₂O₆
  • Molecular Weight: 873.03 g/mol
  • Peptide Sequence: His-D-Trp-Ala-Trp-D-Phe-Lys-NH₂
  • Synonyms: GHRP-6, Growth Hormone Releasing Peptide-6

For laboratory research use only.

GHRP-6 (5mg) Research Uses

In laboratory settings, GHRP-6 is being studied for its role in regulating hormone signaling and metabolic balance. Studies of GHRP-6 often examine how these peptides interact with cellular communication pathways linked to endocrine function.

Researchers explore how GHRP-6 may influence biological systems associated with metabolism, appetite regulation, and cellular signaling. These studies are conducted in controlled environments, such as cell cultures or preclinical models.

The peptide is also being investigated for its interactions with signaling pathways that influence energy balance and cellular responses in hormone-related systems.

GHRP-6 (5mg) Insights & Observed Findings

Experimental studies have evaluated GHRP-6 under controlled laboratory conditions using a range of concentrations to observe cellular responses. Many investigations focus on how exposure to the peptide may influence signaling activity and measurable biological markers.

Published findings describe the use of GHRP-6 in in vitro and preclinical models, where researchers monitor changes in gene activity, signaling pathways, or metabolic indicators. These observations help to better understand peptide-driven biological processes.

The collected data contribute to ongoing scientific understanding of peptide interactions within hormone-related systems.

GHRP-6 (5mg) Handling & Storage

GHRP-6 should be handled according to standard laboratory procedures for peptide-based compounds. The lyophilized material is typically stored at approximately –20°C and protected from light and moisture prior to preparation.

Researchers should allow the vial to reach room temperature before opening to reduce exposure to condensation. Once reconstituted, the solution should be prepared using sterile techniques and stored under refrigerated conditions for laboratory use.

Proper storage and handling practices are recommended throughout GHRP-6 research to help maintain sample integrity and support consistent experimental results.

Compliance Notice: This product is intended for laboratory research use only and is not approved for human or veterinary use. It is not intended for diagnostic, therapeutic, or clinical applications. Any reference to biological activity or potential effects is based solely on preclinical or in-vitro findings and should not be interpreted as validated clinical outcomes. Researchers are responsible for ensuring proper handling, storage, and disposal in accordance with institutional, federal, and international guidelines.

References

  1. Catalina PF, Mallo F, Andrade MA, García-Mayor RV, Diéguez C. Growth hormone (GH) response to GH-releasing peptide-6 in type 1 diabetic patients with exaggerated GH-releasing hormone-stimulated GH secretion. J Clin Endocrinol Metab. 1998;83(10):3663-3667. doi:10.1210/jcem.83.10.5153
  2. de Sá LB, Nascif SO, Correa-Silva SR, et al. Effects of ghrelin, growth hormone-releasing peptide-6, and growth hormone-releasing hormone on growth hormone, adrenocorticotropic hormone, and cortisol release in type 1 diabetes mellitus. Metabolism. 2010;59(10):1536-1542. doi:10.1016/j.metabol.2010.01.021
  3. Cabrales A, Gil J, Fernández E, et al. Pharmacokinetic study of Growth Hormone-Releasing Peptide 6 (GHRP-6) in nine male healthy volunteers. Eur J Pharm Sci. 2013;48(1-2):40-46. doi:10.1016/j.ejps.2012.10.006
  4. Oliveira JH, Vieira JG, Abucham J, Lengyel AM. GHRP-6 is able to stimulate cortisol and ACTH release in patients with Cushing's disease: comparison with DDAVP. J Endocrinol Invest. 2003;26(3):230-235. doi:10.1007/BF03345162